This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Type 2 Diabetes Mellitus
and you are
between 18 and 45
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to estimate the absolute oral bioavailability of dapagliflozin.

Provided treatments

  • Drug: Dapagliflozin
Tris trial is registered with FDA with number: NCT00908271. The sponsor of the trial is AstraZeneca and it is looking for 7 volunteers for the current phase.
Official trial title:
Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects